These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 1746906)
21. Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer. Bièche I; Lidereau R Mol Carcinog; 2000 Nov; 29(3):151-8. PubMed ID: 11108660 [TBL] [Abstract][Full Text] [Related]
22. Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer. Tsai YC; Nichols PW; Hiti AL; Williams Z; Skinner DG; Jones PA Cancer Res; 1990 Jan; 50(1):44-7. PubMed ID: 2293558 [TBL] [Abstract][Full Text] [Related]
23. Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes. Takita K; Sato T; Miyagi M; Watatani M; Akiyama F; Sakamoto G; Kasumi F; Abe R; Nakamura Y Cancer Res; 1992 Jul; 52(14):3914-7. PubMed ID: 1617666 [TBL] [Abstract][Full Text] [Related]
24. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers. Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631 [TBL] [Abstract][Full Text] [Related]
26. Loss of heterozygosity at chromosome 7q in human breast cancer: association with clinical variables. Kristjansson AK; Eiriksdottir G; Ragnarsson G; Sigurdsson A; Gudmundsson J; Barkardottir RB; Jonasson JG; Egilsson V; Ingvarsson S Anticancer Res; 1997; 17(1A):93-8. PubMed ID: 9066635 [TBL] [Abstract][Full Text] [Related]
27. Loss of heterozygosity on chromosome 17p13 in breast carcinomas identifies tumors with high proliferation index. Merlo GR; Venesio T; Bernardi A; Canale L; Gaglia P; Lauro D; Cappa AP; Callahan R; Liscia DS Am J Pathol; 1992 Jan; 140(1):215-23. PubMed ID: 1731526 [TBL] [Abstract][Full Text] [Related]
28. A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus. Jacobs IJ; Smith SA; Wiseman RW; Futreal PA; Harrington T; Osborne RJ; Leech V; Molyneux A; Berchuck A; Ponder BA Cancer Res; 1993 Mar; 53(6):1218-21. PubMed ID: 8095178 [TBL] [Abstract][Full Text] [Related]
29. Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers. Sakamoto T; Nomura N; Mori H; Wake N Gynecol Oncol; 1996 Nov; 63(2):173-9. PubMed ID: 8910623 [TBL] [Abstract][Full Text] [Related]
30. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma. Scholes AG; Liloglou T; Maloney P; Hagan S; Nunn J; Hiscott P; Damato BE; Grierson I; Field JK Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2472-7. PubMed ID: 11581185 [TBL] [Abstract][Full Text] [Related]
31. Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer. Nagai H; Negrini M; Carter SL; Gillum DR; Rosenberg AL; Schwartz GF; Croce CM Cancer Res; 1995 Apr; 55(8):1752-7. PubMed ID: 7712484 [TBL] [Abstract][Full Text] [Related]
32. Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer. Naylor SL; Johnson BE; Minna JD; Sakaguchi AY Nature; 1987 Oct 1-7; 329(6138):451-4. PubMed ID: 2821400 [TBL] [Abstract][Full Text] [Related]
33. Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Futreal PA; Söderkvist P; Marks JR; Iglehart JD; Cochran C; Barrett JC; Wiseman RW Cancer Res; 1992 May; 52(9):2624-7. PubMed ID: 1568230 [TBL] [Abstract][Full Text] [Related]
34. Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread. Tsuda H; Callen DF; Fukutomi T; Nakamura Y; Hirohashi S Cancer Res; 1994 Jan; 54(2):513-7. PubMed ID: 8275489 [TBL] [Abstract][Full Text] [Related]
35. Recurrent deletions involving chromosomes 1, 5, 17, and 18 in colorectal carcinoma: possible role in biological and clinical behavior of tumors. Gerdes H; Chen Q; Elahi AH; Sircar A; Goldberg E; Winawer D; Urmacher C; Winawer SJ; Jhanwar SC Anticancer Res; 1995; 15(1):13-24. PubMed ID: 7733622 [TBL] [Abstract][Full Text] [Related]
36. Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma. Toguchida J; Ishizaki K; Sasaki MS; Ikenaga M; Sugimoto M; Kotoura Y; Yamamuro T Cancer Res; 1988 Jul; 48(14):3939-43. PubMed ID: 2898286 [TBL] [Abstract][Full Text] [Related]
37. Chromosome 17p deletions and p53 mutations in renal cell carcinoma. Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216 [TBL] [Abstract][Full Text] [Related]
38. Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer. An HX; Niederacher D; Picard F; van Roeyen C; Bender HG; Beckmann MW Genes Chromosomes Cancer; 1996 Sep; 17(1):14-20. PubMed ID: 8889502 [TBL] [Abstract][Full Text] [Related]
39. Multiple regions of chromosome 4 demonstrating allelic losses in breast carcinomas. Shivapurkar N; Sood S; Wistuba II; Virmani AK; Maitra A; Milchgrub S; Minna JD; Gazdar AF Cancer Res; 1999 Aug; 59(15):3576-80. PubMed ID: 10446964 [TBL] [Abstract][Full Text] [Related]
40. Genetic alteration mapping on chromosome 7 in primary breast cancer. Bièche I; Khodja A; Driouch K; Lidereau R Clin Cancer Res; 1997 Jun; 3(6):1009-16. PubMed ID: 9815778 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]